News
2023.12.26
Presentation of R&D Pipeline at Biotech Showcase... Seeking Global Partnerships
Dx&Vx announced on the 26th that it will participate in the '2024 JP Morgan Healthcare Conference' and the 'Biotech Showcase 2024' held in San Francisco, USA, conducting partnering meetings.
JP Morgan Healthcare Conference is an event that attracts participants from over 50 countries, including global investors, industry professionals, and companies. The Biotech Showcase, organized annually by EBD Group, is an investor conference within the global bio-partnering forum, with over 3,200 bio-pharmaceutical professionals from around the world attending.
Dx&Vx, actively pursuing a global presence, is set to make its debut participation at the JP Morgan Healthcare Conference and Biotech Showcase following its presence at CPHI WorldWide in Barcelona. Plans to promote its drug development capabilities and showcase new pipeline at these events.
At this event, Dx&Vx plans to discuss various business collaboration opportunities, including global partner identification for new drug development and international market supply of its products. In particular, the Biotech Showcase will see the company participating as a presenting firm, providing insights into key business areas such as cancer vaccines, microbiome-based anticancer drugs, bacteria-based respiratory vaccines, companion diagnostics technology and services, and genomic data analysis.
Additionally, the company will present its pursuit of the acquisition of cancer vaccine OVM-200 from Oxford Vacmedix, clinical trials at Policlinico Universitario Agostistino Gemelli in Rome, and R&D synergies with Coree group, including precision medical diagnostics related to metabolic diseases and management through digital therapeutic solutions.
Kwon Kyu-chan, CEO of DX&VX, said, "We expect that the global market will have a great promotional effect as we plan to hold a presentation and partnering meeting at the biotech showcase for the first time since the company was established during this event. In addition, we plan to accelerate the discovery of global partners through one-on-one meetings with leading pharmaceutical bio companies and investment companies participating in the JP Morgan Healthcare Conference."
Source: Etoday